June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Effect of Co-existing Clinical Signs on Prescribing Patterns for Pediatric Hyperopia
Author Affiliations & Notes
  • Ann Morrison
    The Ohio State University, Columbus, Ohio, United States
  • Marjean T Kulp
    The Ohio State University, Columbus, Ohio, United States
  • Elise B. Ciner
    Salus University, Elkins Park, Pennsylvania, United States
  • Catherine McDaniel
    The Ohio State University, Columbus, Ohio, United States
  • G.Lynn Mitchell
    The Ohio State University, Columbus, Ohio, United States
  • Christine L. Allison
    Illinois College of Optometry, Chicago, Illinois, United States
  • Sandra S Block
    Illinois College of Optometry, Chicago, Illinois, United States
  • David Granet
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • Richard W Hertle
    Akron Children's Hospital, Akron, Ohio, United States
  • Bruce Moore
    New England College of Optometry, Boston, Massachusetts, United States
  • Deborah Orel-Bixler
    University of California Berkeley School of Optometry, Berkeley, California, United States
  • Tawna L Roberts
    Stanford University School of Medicine, Stanford, California, United States
  • Shira L Robbins
    University of California at San Diego Department of Ophthalmology at the Shiley Eye Institute, La Jolla, California, United States
  • M.Millicent Peterseim
    Medical University of South Carolina Albert Florens Storm Eye Institute, Charleston, South Carolina, United States
  • Gayathri Srinivasan
    Stanford University School of Medicine, Stanford, California, United States
  • Gui-Shuang Ying
    University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Ann Morrison None; Marjean Kulp None; Elise Ciner None; Catherine McDaniel None; G.Lynn Mitchell None; Christine Allison None; Sandra Block None; David Granet None; Richard Hertle None; Bruce Moore None; Deborah Orel-Bixler None; Tawna Roberts None; Shira Robbins None; M.Millicent Peterseim None; Gayathri Srinivasan None; Gui-Shuang Ying None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1463. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ann Morrison, Marjean T Kulp, Elise B. Ciner, Catherine McDaniel, G.Lynn Mitchell, Christine L. Allison, Sandra S Block, David Granet, Richard W Hertle, Bruce Moore, Deborah Orel-Bixler, Tawna L Roberts, Shira L Robbins, M.Millicent Peterseim, Gayathri Srinivasan, Gui-Shuang Ying; Effect of Co-existing Clinical Signs on Prescribing Patterns for Pediatric Hyperopia. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1463.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Hyperopia is the most common vision diagnosis in young children, yet there are no evidence-based prescribing guidelines for its management. The purpose of this study was to report current refractive prescribing patterns for children. Here we present prescribing patterns for hyperopia associated with near esophoria or reduced near visual function.

Methods : Pediatric eye care providers were invited to complete an electronic survey evaluating current pediatric spectacle prescribing practices. Questions included what magnitude of bilateral hyperopia the clinician would prescribe for in a child (ages 4 to 7 years and ≥7 years) with 1) age-normal near visual function and no strabismus, 2) moderate or high near esophoria, and 3) reduced near visual function (high accommodative lag, 20/40 or worse near visual acuity, 240” or worse near stereoacuity), the basis for prescribing, and how much hyperopia would be corrected. The distribution of responses given by optometrists (ODs) and ophthalmologists (MDs) was compared using Kolmogorov-Smirnov CDF test.

Results : 593 participants (46.8% ODs) completed these questions. For a child with age-normal near visual function, the level of hyperopia at which 50% of respondents reported prescribing for children 4 to <7 years was +2.5D for ODs, +4D for MDs and for children ≥7 years it was +2D for ODs and +3.5D for MDs. When a near esophoria is present, the level of hyperopia at which 50% of respondents reported prescribing for children 4 to <7 years was +1.5D for ODs and +3.5D for MDs and for children ≥7 years, it was +1D for ODs and +2.5D for MDs. When reduced near visual function was present, the level of hyperopia at which 50% of respondents reported prescribing for children 4 to <7 years was +1D for ODs and +2D for MDs, while for children ≥7 years it was <+1D for ODs and +1D for MDs. The level of hyperopia at which all eye care providers would consider prescribing ranged from <+1D to never. The distribution between ODs and MDs responses was significantly different (P<0.0001). Most ODs and MDs prescribed based on cycloplegic refraction for younger children or a combination of manifest and cycloplegic refraction for older children, commonly 1D to 2D less than the full cycloplegic.

Conclusions : The findings from this survey demonstrate that there are significant and clinically important differences in prescribing patterns for hyperopia among pediatric eye care providers.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×